HB 241 would require health insurers to cover physical therapy, acupuncture, massage therapy, and chiropractic care as ...

As opioid pain medications continue being prescribed for chronic and severe pain, understanding their risks becomes ...

Proponents of the plan to equip paramedics with buprenorphine call it the "missing link" in the bridge to recovery for many ...

Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and ...

The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by ...

Researchers compared a combination of ibuprofen and acetaminophen against hydrocodone for treating pain after wisdom tooth ...

The agreement also ends the Sacklers’ control of Purdue Pharma and prohibits them from selling opioids in the United States.

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

Tris Pharma has pointed to a phase 3 win for its pain relief drug as demonstrating the candidate’s potential to help resolve the opioid crisis. | Tris Pharma has pointed to a phase 3 win for its pain ...

Nearly a quarter of adults in the U.S. have chronic pain, but a new UC Davis study shows a concerning drop in residents ...

Interview: Vivozons oral non-opioid painkiller in development, paving way for U.S. addiction solutions Interview with Vivozon ...

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved ...